DÉRIVÉS DE 4-(P-QUINOLYL)-2-HYDROXYBUTANAMIDE POUR LE TRAITEMENT DE MALADIES MITOCHONDRIALES

• 收藏
• 分享

专利权人:

INC.;EDISON PHARMACEUTICALS

发明人:

申请号：

EP08847883.9

公开号：

EP2220030B1

申请日:

2008.11.04

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The present invention provides specific 4-(p-quinonyl)-2-hydroxybutanamide derivative compounds, pharmaceutical compositions comprising them, and those compounds and compositions for use methods of treating or suppressing a mitochondrial disorder, modulating one or more energy biomarkers, normalizing one or more energy biomarkers, or enhancing one or more energy biomarkers, and treating a subject suffering from a pervasive developmental disorder selected from the group consisting of Autistic Disorder, Asperger's Disorder, Childhood Disintegrative Disorder (CDD), Rett's Disorder, and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/